other material
confidence high
sentiment neutral
materiality 0.20
Anika shareholders approve share reserve increases for equity plans at annual meeting
Anika Therapeutics, Inc.
- Stockholders approved amendment to 2017 Omnibus Incentive Plan, increasing reserved shares from 5,760,000 to 6,110,000 (350,000 share increase).
- Stockholders approved amendment to 2021 Employee Stock Purchase Plan, increasing reserved shares from 200,000 to 400,000 (200,000 share increase).
- Directors Gary P. Fischetti, John B. Henneman III, and Stephen D. Griffin elected as Class III directors until 2029 annual meeting.
- Ratification of Deloitte & Touche as independent auditor for FY2026 passed: 11,136,590 for, 24,966 against, 34,111 abstain.
- Advisory say-on-pay vote passed: 8,268,676 for, 1,093,946 against, 31,179 abstain; 1,801,866 broker non-votes.